What is Laurus Labs Price-to-Operating-Cash-Flow?
As of today (2024-05-30), Laurus Labs's share price is ₹440.15.
Laurus Labs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00. Hence, Laurus Labs's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Laurus Labs's Price-to-Operating-Cash-Flow or its related term are showing as below:
BOM:540222'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0 Med: 16.49 Max: 75.4
Current: 35.54
During the past 11 years, Laurus Labs's highest Price-to-Operating-Cash-Flow Ratio was 75.40. The lowest was 0.00. And the median was 16.49.
Laurus Labs's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ₹0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Laurus Labs was -33.10% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -3.30% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 23.10% per year.
During the past 11 years, Laurus Labs's highest 3-Year average Operating Cash Flow per Share Growth Rate was 44.60% per year. The lowest was -3.70% per year. And the median was 28.40% per year.
Laurus Labs Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Laurus Labs's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laurus Labs Price-to-Operating-Cash-Flow Chart
|
Laurus Labs Annual Data
|
|
Trend |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
9.91 |
26.58 |
34.92 |
15.91 |
31.81 |
|
Laurus Labs Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
15.91 |
- |
- |
- |
31.81 |
Competitive Comparison of Laurus Labs's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Laurus Labs's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laurus Labs's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Laurus Labs's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Laurus Labs's Price-to-Operating-Cash-Flow falls into.
Laurus Labs Price-to-Operating-Cash-Flow Calculation
Laurus Labs's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 440.15 | / | 0 |
| = | |
Laurus Labs's Share Price of today is ₹440.15.
Laurus Labs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Laurus Labs (BOM:540222) Business Description
Traded in Other Exchanges
Address
Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.
Laurus Labs (BOM:540222) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:540222 has been successfully added to your